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A B S T R A C T
Background
Iatrogenic injury of the inferior alveolar or lingual nerve or both is a known complication of oral and maxillofacial surgery procedures.
Injury to these two branches of the mandibular division of the trigeminal nerve may result in altered sensation associated with the
ipsilateral lower lip or tongue or both and may include anaesthesia, paraesthesia, dysaesthesia, hyperalgesia, allodynia, hypoaesthesia
and hyperaesthesia. Injury to the lingual nerve may also affect taste perception on the affected side of the tongue. The vast majority
(approximately 90%) of these injuries are temporary in nature and resolve within eight weeks. However, if the injury persists beyond six
months it is deemed to be permanent. Surgical, medical and psychological techniques have been used as a treatment for such injuries,
though at present there is no consensus on the preferred intervention, or the timing of the intervention.
Objectives
To evaluate the effects of different interventions and timings of interventions to treat iatrogenic injury of the inferior alveolar or lingual
nerves.
Search methods
We searched the following electronic databases: the Cochrane Oral Health Group’s Trial Register (to 9 October 2013), the Cochrane
Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2013, Issue 9), MEDLINE via OVID (1946 to 9 October
2013) and EMBASE via OVID (1980 to 9 October 2013). No language restrictions were placed on the language or date of publication
when searching the electronic databases.
Selection criteria
Randomised controlled trials (RCTs) involving interventions to treat patients with neurosensory defect of the inferior alveolar or lingual
nerve or both as a sequela of iatrogenic injury.
Data collection and analysis
We used the standard methodological procedures expected by The Cochrane Collaboration. We performed data extraction and assess-
ment of the risk of bias independently and in duplicate. We contacted authors to clarify the inclusion criteria of the studies.
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Main results
Two studies assessed as at high risk of bias, reporting data from 26 analysed participants were included in this review. The age range of
participants was from 17 to 55 years. Both trials investigated the effectiveness of low-level laser treatment compared to placebo laser
therapy on inferior alveolar sensory deficit as a result of iatrogenic injury.
Patient-reported altered sensation was partially reported in one study and fully reported in another. Following treatment with laser
therapy, there was some evidence of an improvement in the subjective assessment of neurosensory deficit in the lip and chin areas
compared to placebo, though the estimates were imprecise: a difference in mean change in neurosensory deficit of the chin of 8.40 cm
(95% confidence interval (CI) 3.67 to 13.13) and a difference in mean change in neurosensory deficit of the lip of 21.79 cm (95% CI
5.29 to 38.29). The overall quality of the evidence for this outcome was very low; the outcome data were fully reported in one small
study of 13 patients, with differential drop-out in the control group, and patients suffered only partial loss of sensation. No studies
reported on the effects of the intervention on the remaining primary outcomes of pain, difficulty eating or speaking or taste. No studies
reported on quality of life or adverse events.
The overall quality of the evidence was very low as a result of limitations in the conduct and reporting of the studies, indirectness of
the evidence and the imprecision of the results.
Authors’ conclusions
There is clearly a need for randomised controlled clinical trials to investigate the effectiveness of surgical, medical and psychological
interventions for iatrogenic inferior alveolar and lingual nerve injuries. Primary outcomes of this research should include: patient-
focused morbidity measures including altered sensation and pain, pain, quantitative sensory testing and the effects of delayed treatment.
P L A I N L A N G U A G E S U M M A R Y
Treatments for accidental damage during surgery to the nerves supplying sensation to the tongue, lower lip and chin
Review question
The main question addressed by this review is how effective are different treatments and what are the best timings for these treatments
following accidental damage during surgery to the nerves that supply sensation to the tongue, lower lip and chin.
Background
The nerves (alveolar and lingual) supplying sensation to the tongue, lower lip and chin, may be injured as a result of surgical treatments
to the mouth and face, including surgery to remove lower wisdom teeth. The vast majority (90%) of these injuries are temporary and get
better within eight weeks. However if they last for longer than six months they are considered to be permanent. Damage to these nerves
can lead to altered sensation in the region of the lower lip and chin, or tongue or both. Furthermore, damage to the nerve supplying the
tongue may lead to altered taste perception. These injuries can affect people’s quality of life leading to emotional problems, problems
with socialising and disabilities. Accidental injury after surgery can also give rise to legal action.
There are many interventions or treatments available, surgical and non-surgical, that may enhance recovery, including improving
sensation. They can be grouped as.
1. Surgical - a variety of procedures.
2. Laser treatment - low-level laser treatment has been used to treat partial loss of sensation.
3. Medical - treatment with drugs including antiepileptics, antidepressants and painkillers.
4. Counselling - including cognitive behavioural and relaxation therapy, changing behaviour and hypnosis.
Study characteristics
The Cochrane Oral Health Group carried out this review, and the evidence is current as of 9 October 2013. There are two studies
included, both published in 1996, which compared low-level laser treatment to placebo or fake treatment for partial loss of sensation
following surgery to the lower jaw. There were 15 participants in one study and 16 in the other, their ages ranging from 17 to 55 years.
All had suffered accidental damage to nerves of the lower jaw and tongue causing some loss of sensation following surgery.
Key results
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Low-level laser therapy was the only treatment to be evaluated in the included studies and this was compared to fake or placebo laser
therapy. No studies were found that evaluated other surgical, medical or counselling treatments.
There was some evidence of an improvement when participants reported whether or not sensation was better in the lip and chin areas
with low-level laser therapy. This is based on the results of a single, small study, so the results should be interpreted with caution.
No studies reported on the effects of the treatment on other outcomes such as pain, difficulty eating or speaking or taste. No studies
reported on quality of life or harm.
Quality of the evidence
The overall quality of the evidence is very low as a result of limitations in the conduct and reporting of the two included studies and
the low number of participants, and evidence from participants with only partial sensory loss.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Low- level laser treatment compared with placebo treatment for inferior alveolar and lingual nerve damage
Patient population: Patients with altered sensation due to inferior alveolar nerve injury
Setting: Secondary care (dental hospital)
Intervention: Low- level laser treatment (photon-plus GaA1As diode laser; Rønvig Dental, Denmark: 70 mW output, continuous wavelength of 820 nm)
Comparison: Placebo laser treatment
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk 1 Corresponding risk
Placebo treatment Low- level laser treat-
ment
Pain. This outcome was not
reported in the included
studies.
Sensat ion of
the chin (spontaneous
or evoked - anaesthe-
sia/ paraesthesia/
dysaesthesia/ hyperal-
gesia/ allodynia)
Pat ient-reported out-
come: VAS scale 0 to
10 cm expressed as
change (improvement)
The mean change
in sensat ion in the
placebo group was -0.
68 cm
The mean change in
sensat ion in the treat-
ment group was 8.40
cm greater (95% CI 3.
67 to 13.13) than in the
placebo group
13 (1) ⊕©©©
very low 2
A posit ive change value
indicates that neu-
rosensory def icit was
less post-treatment, i.e.
an increase in subjec-
t ive sensat ion
The relat ive ef fect
of the intervent ion is
greater for the lip (13
pat ients analysed, MD
21.79, 95% CI 5.29 to
38.29) but imprecise
Dif f iculty eat ing. This outcome was not
reported in the included
studies.
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Dif f iculty speaking. This outcome was not
reported in the included
studies.
Taste. This outcome was not
reported in the included
studies.
Adverse events. This outcome was not
reported in the included
studies.
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval; M D: mean dif ference; VAS: visual analogue scale.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 The basis for the assumed risk was the mean of the control group in the single included study.
2 One, small t rial assessed at high risk of bias. Imprecision of ef fect est imate and lim ited applicability as the trial included a
small number of pat ients with only part ial sensory loss.
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B A C K G R O U N D
The lingual and inferior alveolar nerves are branches of the third,
or mandibular division, of the trigeminal nerve. The lingual nerve
provides innervation to the ipsilateral anterior two-thirds of the
tongue and the lingual mandibular gingivae, while the inferior
alveolar nerve supplies sensation to the ipsilateral lower lip, buc-
cal mandibular gingivae and teeth. The anatomical position of
these nerves places them at increased risk of injury during certain
surgical procedures. Iatrogenic injury of the inferior alveolar or
lingual nerve is a relatively rare but serious sequelae of oral and
maxillofacial surgery procedures. The aetiology of injuries to these
nerves includes: dental local anaesthetic injection, third lower mo-
lar surgery, dental implant placement or removal, endodontic ther-
apy, trauma, ablative surgery, orthognathic surgery, intubation,
and submandibular gland surgery.
Description of the condition
Injury to the inferior alveolar nerve can result in impaired sensation
to the area innervated by the damaged nerve, including altered
sensation associated with the ipsilateral lower lip, chin, buccal
mandibular gingivae and dentition. Damage to the lingual nerve
may cause unilateral sensory deficit of the anterior two-thirds of
the tongue and the lingual mandibular gingivae.
The impaired sensation can be classified as (www.iasp-pain.org).
• Paraesthesia - An abnormal sensation, whether spontaneous
or evoked.
• Anaesthesia - Complete absence of perception of stimuli
including touch.
• Dysaesthesia - An unpleasant abnormal sensation, whether
spontaneous or evoked.
• Hyperalgesia - Increased pain from a stimulus that normally
provokes pain.
• Allodynia - Pain due to a stimulus that does not normally
provoke pain.
• Hypoaesthesia - Decreased sensitivity to stimulation,
excluding the special senses.
• Hyperaesthesia - Increased sensitivity to stimulation,
excluding the special senses.
The injury to the lingual nerve may also affect taste perception on
the same side.
• Ageusia - Loss of taste perception.
• Dysgeusia - Altered taste perception.
The vast majority (approximately 90%) of these injuries are tem-
porary in nature and resolve within eight weeks (Blackburn 1990;
Mason 1988; Pogrel 2001). However, if the injury persists beyond
six months it is deemed to be permanent (Rood 1990). Neurosen-
sory disturbances arising from damage to the inferior alveolar or
lingual nerve can cause significant distress; patients often complain
of a lower quality of life, psychological discomfort, and social dis-
ability and handicap (Lam 2003;Meyer 2001). Iatrogenic injuries
are also a prevalent medico-legal issue.
Description of the intervention
This review is based on a Cochrane protocol ’Interventions for ia-
trogenic inferior alveolar nerve injury’ (New Reference). There are
a number of reported interventions for the treatment of iatrogenic
nerve injury; they can be categorised as follows.
(1) Surgical intervention.
• External neurolysis: This is a technique that involves
releasing the nerve from its connective tissue bed and removing
any restrictive fibrous/scar tissue or bone. Injury to the
surrounding tissue may result in scar tissue formation which may
cause compression/constriction of the nerve and block nerve
transmission, or in some cases prevent nerve recovery
(Greenwood 2005; Joshi 2002).
• Internal neurolysis: This is a technique that aims to
examine and release the nerve fascicles from epineural fibrosis. It
is indicated where there is evidence of nerve fibrosis and
associated changes in the appearance of the nerve. This
procedure is not recommended by some surgeons as it may lead
to further scar tissue formation (Ziccardi 2007).
• Neurorrhaphy: This method is also called coaptation or
direct anastomosis. It is indicated where the nerve is transected
and its two ends can be sutured together without tension.
Usually, defects of less than 1 cm can be repaired by direct
suture. Immediate repair using this method is advocated when a
nerve transection is witnessed (Tay 2008). The repair is by
approximation of the two ends and application of epineural
sutures.
• Neuroma excision: The formation of a neuroma is the
result of disorganised axonal regeneration or sprouting at the
injury site in an attempt to reach the distal stump. The aetiology
of this injury may include not only section of the nerve but also
crushing, laceration, stretching, and the pathological effects of
objects such as root tips, endodontic medicaments, implants etc
(Chau 1989; Gregg 1990). It may be in the form of an
amputation neuroma, lateral neuroma or neuroma in continuity.
The nerve fibres within a neuroma may show abnormal
spontaneous activity or mechanical sensitivity resulting in the
development of sensory disorders such as dysaesthesia (Devor
1994). The surgical treatment of choice is excision of the
neuroma, followed by direct apposition and suturing, or grafting
depending on whether the nerve stumps can be approximated
without tension.
• Autologous nerve grafting: This method allows for bridging
of a defect between nerve stumps in cases where the post-injury
defect does not allow for direct approximation of the neural ends
without tension. The donor tissue for such interpositional grafts
is usually the sural nerve, greater auricular nerve or medial
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antebrachial nerve (Eppley 1991; Jones 1992; Wessberg 1982).
However, autologous nerve graft techniques involve unavoidable
donor site morbidity. Alternatively, denatured skeletal muscle
autografts can be used (Rath 2002).
• Tubulization: In cases where post-injury defects do not
allow for direct apposition, a hollow conduit structure can also
be used that allows nerve regeneration to occur. Autologous as
well as alloplastic materials can be used. Pogrel 2001 advocates
the use of saphenous vein for repair of the lingual nerve and
facial vein for inferior alveolar nerve repair. Alloplastic conduits
for reconstruction of lingual and inferior alveolar nerve defects
include: polyglycolic acid (PGA) bioabsorbable tubes (Crawley
1992), PGA-collagen tubes (Seo 2008), collagen tubes
(NeuraGen) (Farole 2008), and Gore-Tex tubes (Pitta 2001;
Pogrel 1998). However, there is general agreement that more
studies in the field are necessary.
(2) Laser treatment.
Low-level laser therapy has been used for the treatment of partial
sensory loss in patients suffering from iatrogenic injuries to the
inferior alveolar nerve (Khullar 1996a; Khullar 1996b). The appli-
cation of the laser treatment before and after surgical procedures
including sagittal split osteotomies has been shown to speed up
the recovery process (Miloro 2000).
(3) Medical treatment.
Injury to a peripheral nerve may result in changes within the cen-
tral nervous system. Dysfunction of the peripheral and central
neurons may lead to the development of neuropathic pain. The
pharmacological treatment of this condition is based on the fol-
lowing medications: antiepileptics, antidepressants and analgesics
(Clark 2008; Heir 2008). These drugs can be administered via
enteral and topical routes.
(4) Counselling.
This group of interventions includes psychological treatment and
sensory re-education methods (Meyer 2001). These may employ
the following techniques: cognitive behavioural therapy, relaxation
therapy, behaviour modification, electromyographic biofeedback,
and hypnosis (Dworkin 1997, Feinmann 2004).
How the intervention might work
The aim for any intervention for the treatment of peripheral sen-
sory nerve injury is to improve the neurosensory perception and
therefore the quality of life of the patient.However, althoughmany
attempts have been made to improve results, these have had lim-
ited success, outcomes to date have been variable, and full recov-
ery is extremely difficult to achieve. Ultimately any intervention
should aim to reduce morbidity and improve the patient’s quality
of life.
Why it is important to do this review
At present, there appears to be no consensus on the type of inter-
vention (surgical, medical, psychological), or the timing of inter-
vention for the treatment of iatrogenic alveolar and lingual nerve
injury. Given the morbidity and significant psychological distress
arising from such injuries it is important to establish the effects of
the available interventions.
O B J E C T I V E S
To evaluate the effects of different interventions and timings of
interventions to treat iatrogenic injury of the inferior alveolar or
lingual nerves.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised controlled trials (RCTs) comparing interventions
for the treatment of iatrogenic inferior alveolar or lingual nerve
injury. We planned to include trials comparing an active inter-
vention to no treatment and trials that directly compared active
interventions. We planned to included trials of interventions at
any time point.
Types of participants
Patients of any age in any setting requiring intervention for iatro-
genic injury to the inferior alveolar or lingual nerve.
Types of interventions
Comparisons of different active interventions (at all reported time
points), or comparisons of different interventions with no treat-
ment. We also planned to include trials of the same intervention
delivered at different time points. For the purpose of analysis we
have categorised the treatments as follows.
• Surgical: exploration and external neurolysis, internal
neurolysis, neurorrhaphy, neuroma excision, tubulization,
grafting, laser.
• Medical: systemic medications (analgesics, antidepressants,
antiepileptics, steroids), topical agents (analgesics, anaesthetics).
• Psychological: counselling, acupuncture, cognitive
behavioural therapy, relaxation therapy, behaviour modification,
electromyographic biofeedback, hypnosis, re-education.
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Types of outcome measures
Primary outcome measures
• Pain.
• Patient-reported altered sensation (spontaneous or evoked -
anaesthesia/paraesthesia/dysaesthesia/hyperalgesia/allodynia).
• Difficulty eating.
• Difficulty speaking.
• Taste.
Secondary outcome measures
• Quality of life/patient satisfaction.
• Adverse events.
• Mechanosensory (pin prick/two-point/light touch/pressure
thresholds/pain thresholds/thermal thresholds).
• Thermosensory.
• Somatosensory evoked potentials.
The primary outcomes were chosen to reflect the importance of
patient-reported outcomes.
Where outcomes were deemed to be measuring the same concept
but measured in different ways (e.g. using different measurement
scales), we planned to combine the outcomes, using statistical
measures (e.g. standardised mean difference) where appropriate.
If outcomes are measured at multiple time points we planned to
categorise the time of measurement as closest to < 3 months, < =
6 months and > 6 months post-operative.
Search methods for identification of studies
Detailed search strategies were developed for each database
searched. No restrictions were placed on the language of publi-
cation when the electronic databases were searched. These were
based on the search strategy developed for MEDLINE (OVID)
but revised appropriately for each database. The search strategy
combined the subject search with the Cochrane Highly Sensitive
Search Strategy for identifying randomised trials inMEDLINE, as
published in the Cochrane Handbook for Systematic Reviews of In-
terventions (Higgins 2011), chapter 6.4.11.1. The search strategy
used a combination of controlled vocabulary and free text terms.
Searches were undertaken in October 2013.
Electronic searches
We searched the following electronic databases:
• the Cochrane Oral Health Group’s Trial Register (to 9
October 2013) (Appendix 1);
• the Cochrane Central Register of Controlled Trials
(CENTRAL) (The Cochrane Library 2013, Issue 9) (Appendix 2);
• MEDLINE via OVID (1946 to 9 October 2013)
(Appendix 3);
• EMBASE via OVID (1980 to 9 October 2013) (Appendix
4).
Searching other resources
The bibliographies of identified RCTs and review articles were
checked for additional studies.
Handsearching
Handsearching was performed by staff at the Cochrane Oral
HealthGroup using specially selected journals. The list of the den-
tal journals handsearched by the Cochrane Oral Health Group
can be found on the following website (www.ohg.cochrane.org/
handsearching.html). The following journals were identified as
being important to be handsearched for this review: British Jour-
nal of Oral and Maxillofacial Surgery, International Journal of Oral
and Maxillofacial Surgery, Journal of the American Dental Associa-
tion, Journal of Dental Research, Journal of Oral and Maxillofacial
Surgery, Oral Surgery Oral Medicine Oral Pathology Oral Radiology
and Endodontics, Journal of the American Dental Association, Aus-
tralian Dental Journal, British Dental Journal, Journal of Orofacial
Pain, and European Journal of Oral Sciences.
Unpublished studies
The ClinicalTrials.gov and WHO International Clinical Trials
Registry Platform were searched in October 2013 for ongoing
studies. Personal contacts were also used to identify unpublished
RCTs.
Data collection and analysis
Selection of studies
Three review authors scanned independently the titles and ab-
stracts (where available) of all reports identified by the search strat-
egy. For studies that appeared to meet the inclusion criteria or for
which there was insufficient information in the title or abstract
to make a clear decision, the full report was obtained. These were
assessed independently by at least two review authors to estab-
lish whether the studies were eligible for inclusion. Disagreements
were resolved by discussion. Where resolution was not possible, we
planned to consult a third review author but this was not necessary.
Any studies rejected at this or subsequent stages were recorded in
the Characteristics of excluded studies table, and the reason for
exclusion recorded.
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Data extraction and management
Three review authors extracted data independently using a spe-
cially designed and piloted data extraction form. Any disagreement
or points that required clarification were discussed and resolved
through discussion. It was agreed that trial authors would be con-
tacted for clarification of missing or ambiguous information/data
if required.
For each trial the following data were recorded.
• Year of publication, country of origin and source of study
funding.
• Study design.
• Details of the participants including demographic
characteristics, source of recruitment and criteria for inclusion.
• Details of the type and timing of the intervention and
comparator.
• Details of the outcomes reported, including method and
timing of assessment.
Where summary outcome data were not fully reported we planned
to use information from effect estimates, confidence intervals and
test statistics wherever possible.
Assessment of risk of bias in included studies
The assessment of risk of bias of the included trials was undertaken
independently and in duplicate by the review authors as part of
the data extraction process. We used the recommended approach
for assessing risk of bias in studies included in Cochrane reviews
(Higgins 2011). We assessed each study on six specific domains
(namely sequence generation, allocation concealment, blinding,
incomplete outcome data, selective outcome reporting and other
sources of bias) and assigned a risk of bias of low, high or unclear for
each domain. For the blinding domain we assessed separately the
risk of bias from blinding of participants/personnel and outcome
assessors.
After carrying out the risk of bias assessments, included studies
were categorised as illustrated in Additional Table 1.
We completed a risk of bias table for each included study and
presented the results graphically (Figure 1).
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Figure 1. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
Measures of treatment effect
For dichotomous outcomes, the estimate of effect of an interven-
tion was planned to be expressed as risk ratios together with 95%
confidence intervals (CIs); mean differences and 95%CIs for con-
tinuous outcomes measured on the same scale and standardised
mean differences and 95%CIs for continuous outcomes measured
on different scales. For ease of interpretation we planned to re-
express the standardised mean difference on a known scale.
Dealing with missing data
Where information about the study design or outcome measures
was unclear or missing, we contacted authors of the studies in
order to obtain further information about the trial.
Assessment of heterogeneity
We planned to assess clinical heterogeneity through examining
the types of participants and interventions for all outcomes in
each study. We planned to assess statistical heterogeneity through
Cochran’s test of heterogeneity and the I2 statistic. Only if there
were studies of similar comparisons reporting the same outcome
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measures would meta-analyses haven been carried out.
Data synthesis
Data synthesis was planned using risk ratios for dichotomous data
and mean differences or standardised mean differences for contin-
uous data, together with 95% CIs. Each intervention would be
categorised according to surgery, medical or psychological as per
Types of interventions section.Where the information was limited
we planned to use a fixed-effect model to pool the data; we would
use a random-effects model with a larger number of studies of the
same comparison.
For each comparison, we considered whether pooling of results
through a meta-analysis was appropriate, based on clinical and
methodological characteristics of the studies.Where there was het-
erogeneity that could not readily be explained we would consider
a random-effects model. With this approach, the confidence in-
tervals for the average intervention effect would be wider than
those obtained with a fixed-effect approach, leading to a more
conservative interpretation. When information is limited, either
because there are few studies or if the studies are small, a random-
effects analysis would provide poor estimates of the width of the
distribution of intervention effects and in such instances we would
provide a narrative report of the results.
Subgroup analysis and investigation of heterogeneity
Subgroup analyses were to be undertaken in respect of the experi-
ence of surgeon (junior/senior) and the timing of the intervention
(< 3 months, < = 6 months and > 6 months post-operative).
Sensitivity analysis
We planned to undertake sensitivity analyses to examine the effect
of blinded outcome assessment on the overall estimates of effect
for each intervention.
Presentation of main results
A summary of findings table was developed for the primary out-
comes of this review using GRADEProfiler software. The quality
of the body of evidence was assessed with reference to the overall
risk of bias of the included studies. the directness of the evidence,
the inconsistence of the results, the precision of the estimates, the
risk of publication bias, the magnitude of effect and whether or
nor there was evidence of a dose response. The quality of the body
of evidence for each of the primary outcomes was categorised as
high, moderate, low or very low.
R E S U L T S
Description of studies
Results of the search
The electronic search identified a total of 554 publications of
which 405 remained after removing duplicates. Two review au-
thors independently screened the titles and abstracts (where avail-
able) for eligibility. 25 publications were considered potentially
eligible and full text copies were obtained. Of his number, 23
studies were considered ineligible for inclusion as they were not
randomised controlled trials (RCTs).
No additional eligible trials were found as a result of handsearch-
ing, contact with authors or searching references lists of relevant
publications. Two ongoing studies were identified. (Figure 2).
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Figure 2. Study flow diagram.
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Included studies
Two RCTs were included in this review, one conducted in Nor-
way (Khullar 1996a) and the other in Sweden (Khullar 1996b).
Both trials used a parallel study design and compared the effect of
surgical intervention (low-level laser treatment) versus placebo. A
total of 31 patients were randomised across the two trials and 26
patients were evaluated. Information about the trials is provided
in the Characteristics of included studies section.
No studies evaluated medical or psychological interventions.
Excluded studies
23 studies were excluded from the review as they were not RCTs
(for reference see Characteristics of excluded studies table).
Risk of bias in included studies
The overall risk of bias assessments for the two included studies
are shown in Figure 1. Both studies were assessed as at high risk
of bias overall, arising from selective outcome reporting (Khullar
1996a) and incomplete outcome data (Khullar 1996b).
Allocation
No information was provided about allocation concealment or
sequence generation in either included study (Khullar 1996a;
Khullar 1996b). We classified both trials as being at unclear risk
of selection bias.
Blinding
We assessed both studies at low risk of performance bias and de-
tection bias (Khullar 1996a; Khullar 1996b).
Incomplete outcome data
Post-randomisation exclusions were minimal and evenly dis-
tributed across the intervention and comparator groups in one
trial (Khullar 1996a) which we assessed as at low risk of attrition
bias, but were significant and unevenly distributed (all exclusions
in the placebo arm) in the other trial (Khullar 1996b), which we
assessed as at high risk of attrition bias.
Selective reporting
Subjective rating of sensory function was incompletely reported
(text in the abstract only) in one study which we assessed as at
high risk of reporting bias (Khullar 1996a), while all outcome data
were fully reported in the second (Khullar 1996b).
Other potential sources of bias
Both studies appeared to be free of other sources of bias.
Effects of interventions
See: Summary of findings for the main comparison
The only intervention to be evaluated in the included studies was
surgery (low-level laser) and this was compared to placebo laser.
No studies evaluated medical or psychological interventions.
Surgical intervention (low-level laser) compared to
placebo (placebo laser)
Two, two-arm, parallel group trials (Khullar 1996a; Khullar
1996b) compared the effect of surgical intervention (low-level
laser treatment) versus placebo (placebo laser) for the treatment
of inferior alveolar nerve injury. A total of 31 patients were ran-
domised across the two trials. Of the primary outcome measures
for evaluation in this review, only subjective rated altered sensation
was reported in the included studies. One study with 13 analysed
patients reported patient’s subjective assessment of the degree of
sensory deficit on a 10 cm visual analogue scale (VAS) (Khullar
1996b). There was some evidence of an effect, with the laser group
reporting an improvement in subjective assessment of neurosen-
sory deficit (i.e. a reduction in degree of sensory deficit), as mea-
sured by the VAS scale. This was observed for both sites of mea-
surement: the chin (mean difference (MD) 8.40; 95% confidence
interval (CI) 3.67 to 13.13) and the lip (MD 21.79; 95% CI 5.29
to 38.29). The confidence intervals were relatively wide, indicating
imprecision of the estimate of effect. In the second study (Khullar
1996a) a subjective improvement in sensory function for the laser
group was reported in abstract but no details of this outcome were
reported in the methods or results section of the paper. The over-
all quality of evidence for this outcome was assessed as very low
(Summary of findings for the main comparison).
No studies reported on pain, difficulty eating or speaking or taste.
Of the secondary outcome measures for evaluation in this review,
only mechanosensory and thermosensory outcomes were reported
(two studies, 26 patients analysed).
• Mechanosensory perception was tested using Semmes
Weinstein monofilaments (North Coast Medi-Tek, San Jose,
California, USA). Khullar 1996a reported a statistically
significant difference in the change in load (g) necessary to elicit
a sensation between the treatment and placebo groups (13
patients analysed, MD 1.07; 95% CI 0.17 to 1.97) in favour of
the treatment group. This finding was not observed in the
second study (Khullar 1996b); on average, there was a greater
reduction in load (g) necessary to elicit a sensation for patients
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with neurosensory deficit of the lip and chin in the treatment
group than the control group. These results were not statistically
significant however, the range of effects within the confidence
intervals included no intervention effect and a beneficial effect of
the intervention (13 patients analysed with neurosensory deficit
of the chin, MD 0.54; 95% CI -0.12 to 1.19; 10 patients
analysed with neurosensory deficit of the lip, MD 0.50; 95% CI
-0.33 to 1.32).
• Both studies reported no significant changes in thermal
perception with treatment (Khullar 1996a; Khullar 1996b);
there was no evidence of an improvement in thermal perception
with the low-level laser compared to placebo laser (12 patients
analysed, MD 1.79; 95% CI -2.04 to 5.62; 13 patients analysed,
MD 3.21; 95% CI -1.67 to 8.09). In the second study “normal
pre-treatment values were excluded from statistical analysis”
which meant that results are available only for the site of left chin
and not for the sites of right chin, left and right lip.
No studies reported on quality of life, somatosensory evoked po-
tentials, or adverse events.
D I S C U S S I O N
Summary of main result
Despite the large number of studies detailing different interven-
tions for the treatment of iatrogenic trigeminal nerve injury, we
found only two, small, low quality randomised controlled trials
of laser therapy which were eligible for inclusion in this review.
Surgical and non-surgical methods have been reported as benefi-
cial in some circumstances for the improvement of neurosensory
deficit. However, such methods have yet to be fully evaluated in
randomised controlled trials, and at present, no firm conclusions
can be drawn as to whether any of these methods provide benefi-
cial results. There is also a lack of trials directly comparing these
methods or addressing the issue of optimal timing for carrying
out the procedure. There are two ongoing studies (Chiung Shing
Huang and Yu-Fang Liao). Despite the fact that they are both ac-
tive randomised controlled trials, they are currently not recruiting
participants.
Overall completeness and applicability of
evidence
It has not been possible to fully achieve the objectives of this review
as there is a lack of trialsmeeting the inclusion criteria. The number
of included studies was low (two), and these only compared one
type of intervention (laser treatment) against a placebo; crucially,
the total number of participants randomised (31) was too few to
fully address the efficacy of the intervention.
There were no studies evaluating the effects of other surgical in-
terventions, or medical or psychological interventions.
The included studies reported on only one (altered sensation) of
the five patient-reported primary outcomes for evaluation in this
review.
Quality of the evidence
These trials (Khullar 1996a; Khullar 1996b) cannot be considered
as a valuable source of information on how to manage iatrogenic
trigeminal nerve injury. The overall quality of the evidence was
very low, a judgement based on limitations in the implementation
and reporting of the trials and the imprecision of the results for the
outcomeswhere reported, directness of the evidence (a small group
of patients with only partial sensory loss). There is insufficient
evidence that low-level laser therapy leads to improved or quicker
neurosensory recovery and thus contributes to improvement of
patients’ quality of life.
Agreements and disagreements with other
studies or reviews
This review includes only laser treatment for iatrogenic inferior
alveolar nerve injury due to a lack of randomised controlled trials
for other interventions. Nevertheless Miloro 2000 also reports
positive results using low-level laser for sensation recovery after
nerve damage.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There is a lack of evidence to support or refute the effects of the
surgical, medical and psychological interventions in the treatment
of inferior alveolar or lingual nerve injury, and very low quality
evidence to support the effects of laser therapy on patient-reported
altered sensation. Despite the lack of evidence, we should not
abandon the development of early referral criteria from general
practitioners to specialist centres. All front-line healthcare staff
should be educated and trained in this area to increase and improve
awareness, and to recognise and provide support for people with
these injuries. This training should emphasize the competence of
the surgeon, methods to help avoid iatrogenic nerve injury, and
the effect these injuries can have on a patient’s quality of life.
Implications for research
There is a need for randomised controlled clinical trials to investi-
gate the effectiveness of surgical, medical and psychological inter-
ventions for iatrogenic inferior alveolar and lingual nerve injuries.
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These trials should be conducted in specialist centres seeing large
numbers of patients presenting with inferior alveolar or lingual
nerve injury. Primary outcomes of such research should include:
patient-focusedmorbiditymeasures, altered sensation, pain, quan-
titative sensory testing and the effects of delayed treatment. Im-
proved partnership between local general practitioners in the pri-
mary care setting and secondary specialist healthcare organisations
may be the first crucial step in the development of such trials in
this area.
A C K N OW L E D G E M E N T S
Wewish to thankAnneLittlewood (CochraneOralHealthGroup)
for her assistance with literature searching; Anne-Marie Glenny
(CochraneOralHealthGroup) for her helpwith the preparationof
this review; and Katarzyna Atsbury for her contribution to earlier
versions of this review.
R E F E R E N C E S
References to studies included in this review
Khullar 1996a {published and unpublished data}
Khullar SM, Brodin P, Barkvoll P, Haanæs HR. Preliminary
study of low-level laser for treatment of long-standing
sensory aberrations in the inferior alveolar nerve. Journal of
Oral and Maxillofacial Surgery 1996;54(1):2–7.
Khullar 1996b {published and unpublished data}
Khullar SM, Emami B, Westermark A, Haanæs HR.
Effect of low-level laser treatment on neurosensory
deficits subsequent to sagittal split ramus osteotomy. Oral
Surgery, Oral Medicine, Oral Pathology, Oral Radiology and
Endodontics 1996;82(2):132–8.
References to studies excluded from this review
Blackburn 1992 {published and unpublished data}
Blackburn CW. Experiences in lingual nerve repair. British
Journal of Oral and Maxillofacial Surgery 1992;30(2):72–7.
Cornelius 1997 {published and unpublished data}
Cornelius CP, Roser M, Ehrenfeld M. Microneural
reconstruction after iatrogenic lesions of the lingual nerve
and the inferior alveolar nerve. Critical evaluation. Mund-,
Kiefer- und Gesichtschirurgie 1997;4:213–23.
Crawley 1992 {published and unpublished data}
Crawley WA, Dellon AL. Inferior alveolar nerve
reconstruction with a polyglycolic acid bioabsorbable nerve
conduit. Plastic and Reconstructive Surgery 1992;90(2):
300–2.
Farole 2008 {published and unpublished data}
Farole A, Jamal BT. A bioabsorbable collagen nerve cuff
(NeuraGen) for repair of lingual and inferior alveolar nerve
injuries: a case series. Journal of Oral and Maxillofacial
Surgery 2008;66(10):2058–62.
Greenwood 2005 {published and unpublished data}
Greenwood M, Corbett IP. Observations on the exploration
and external neurolysis of injured inferior alveolar nerves.
International Journal of Oral and Maxillofacial Surgery 2005;
34(3):252–6.
Grötz 1998 {published and unpublished data}
Grötz KA, Al-Nawas B, de Aguiar EG, Schulz A, Wagner
W. Treatment of injuries to the inferior alveolar nerve after
endodontic procedures. Clinical Oral Investigations 1998;2
(2):73–6.
Hillerup 1994 {published and unpublished data}
Hillerup S, Hjørting-Hansen E, Reumert T. Repair of the
lingual nerve after iatrogenic injury: a follow-up study
of return of sensation and taste. Journal of Oral and
Maxillofacial Surgery 1994;52(10):1028–31.
Hillerup 2007 {published and unpublished data}
Hillerup S, Stoltze K. Lingual nerve injury II.
Observations on sensory recovery after micro-neurosurgical
reconstruction. International Journal of Oral and
Maxillofacial Surgery 2007;36(12):1139–1145.
Hillerup 2008 {published and unpublished data}
Hillerup S. Iatrogenic injury to the inferior alveolar nerve:
etiology, signs and symptoms, and observations on recovery.
International Journal of Oral and Maxillofacial Surgery 2008;
37(8):704–9.
Joshi 2002 {published and unpublished data}
Joshi A, Rood JP. External neurolysis of the lingual nerve.
International Journal of Oral and Maxillofacial Surgery 2002;
31(1):40–3.
Miloro 2000 {published and unpublished data}
Miloro M, Repasky M. Low-level laser effect on
neurosensory recovery after sagittal ramus osteotomy. Oral
Surgery, Oral Medicine, Oral Pathology, Oral Radiology and
Endodontics 2000;89(1):12–8.
Mozsary 1984 {published and unpublished data}
Mozsary PG, Middleton RA. Microsurgical reconstruction
of the lingual nerve. Journal of Oral and Maxillofacial
Surgery 1984;42(7):415–20.
Pitta 2001 {published and unpublished data}
Pitta MC, Wolford LM, Mehra P, Hopkin J. Use of Gore-
Tex tubing as a conduit for inferior alveolar and lingual
nerve repair: experience with 6 cases. Journal of Oral and
Maxillofacial Surgery 2001;59(5):493–6.
Pogrel 1998 {published and unpublished data}
Pogrel MA, McDonald AR, Kaban LB. Gore-Tex tubing as
a conduit for repair of lingual and inferior alveolar nerve
continuity defects: a preliminary report. Journal of Oral and
Maxillofacial Surgery 1998;56(3):319–21.
15Interventions for iatrogenic inferior alveolar and lingual nerve injury (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Pogrel 2001 {published and unpublished data}
Pogrel MA, Maghen A. The use of autogenous vein grafts
for inferior alveolar and lingual nerve reconstruction.
Journal of Oral and Maxillofacial Surgery 2001;59(9):985–8.
Robinson 1996 {published and unpublished data}
Robinson PP, Smith KG. A study on the efficacy of late
lingual nerve repair. British Journal of Oral and Maxillofacial
Surgery 1996;34(1):96–103.
Rutner 2005 {published and unpublished data}
Rutner TW, Ziccardi VB, Janal MN. Long-term outcome
assessment for lingual nerve microsurgery. Journal of Oral
and Maxillofacial Surgery 2005;63(8):1145–9.
Schultes 2000 {published and unpublished data}
Schultes G, Gaggl A, Kärcher H. Vascularized
transplantation of the long thoracic nerve for sensory
reinnervation of the lower lip. British Journal of Oral and
Maxillofacial Surgery 2000;38(2):138–41.
Seo 2008 {published and unpublished data}
Seo K, Inada Y, Terumitsu M, Nakamura T, Horiuchi K,
Inada I, et al. One year outcome of damaged lingual nerve
repair using a PGA-collagen tube: a case report. Journal of
Oral and Maxillofacial Surgery 2008;66(7):1481–4.
Strauss 2006 {published and unpublished data}
Strauss ER, Ziccardi VB, Janal MN. Outcome assessment
of inferior alveolar nerve microsurgery: a retrospective
review. Journal of Oral and Maxillofacial Surgery 2006;64
(12):1767–70.
Susarla 2007 {published and unpublished data}
Susarla SM, Kaban LB, Donoff RB, Dodson TB. Functional
sensory recovery after trigeminal nerve repair. Journal of
Oral and Maxillofacial Surgery 2007;65(1):60–5.
Tay 2008 {published and unpublished data}
Tay ABG, Poon CY, Teh LY. Immediate repair of transected
inferior alveolar nerves in sagittal split osteotomies. Journal
of Oral and Maxillofacial Surgery 2008;66(12):2476–81.
Zuniga 1997 {published and unpublished data}
Zuniga JR, Chen N, Phillips CL. Chemosensory and
somatosensory regeneration after lingual nerve repair in
humans. Journal of Oral and Maxillofacial Surgery 1997;55
(1):2–13.
References to ongoing studies
Chiung Shing Huang {unpublished data only}
Sensory retraining exercise facilitates sensory recovery after
bilateral sagittal split osteotomy - a randomised controlled
trial.. Ongoing study April 2012..
Yu-Fang Liao {unpublished data only}
Inferior alveolar nerve injury after bilateral sagittal split
osteotomy in oral clefts.. Ongoing study June 2013..
Additional references
Blackburn 1990
Blackburn CW. A method of assessment in cases of lingual
nerve injury. British Journal of Oral and Maxillofacial
Surgery 1990;284(4):238–45.
Chau 1989
Chau MNY, Jönsson E, Lee KM. Traumatic neuroma
following sagittal mandibular osteotomy. International
Journal of Oral and Maxillofacial Surgery 1989;18(2):95–8.
Clark 2008
Clark G. Top 60 medications used for orofacial pain
treatment. Journal of the Californian Dental Association
2008;36(10):747–67.
Devor 1994
Devor M. The pathophysiology of damaged peripheral
nerves. In: Wall PD, Melzack R editor(s). Textbook of Pain.
London: Churchill Livingston, 1994.
Dworkin 1997
Dworkin SF. Behavioral and educational modalities. Oral
Surgery, Oral Medicine, Oral Pathology, Oral Radiology and
Endodontics 1997;83(1):128–33.
Eppley 1991
Eppley BL, Snyders RV. Microanatomic analysis of the
trigeminal nerve and potential nerve graft donor sites.
Journal of Oral and Maxillofacial Surgery 1991;49(6):612–8.
Feinmann 2004
Feinmann C, Newton-John T. Psychiatric and psychological
management considerations associated with nerve damage
and neuropathic trigeminal pain. Journal of Orofacial Pain
2004;18(4):360–5.
Gregg 1990
Gregg JM. Studies of traumatic neuralgias in the
maxillofacial region: surgical pathology and neural
mechanisms. Journal of Oral and Maxillofacial Surgery
1990;48(3):228–37.
Heir 2008
Heir G, Karolchek S, Kalladka M, Vishwanath A, Gomes
J, Khatri R, et al. Use of topical medication in orofacial
neuropathic pain: a retrospective study. Oral Surgery, Oral
Medicine, Oral Pathology, Oral Radiology and Endodontics
2008;105(4):466–9.
Higgins 2011
Higgins JPT, Green S (editors). Cochrane Handbook
for Systematic Reviews of Interventions version 5.1.0
(updated March 2011). The Cochrane Collaboration,
2011. Available from www.cochrane-handbook.org.
Jones 1992
Jones RHB. Microsurgical repair of nerves injured during
third molar surgery. Australian Dental Journal 1992;37(4):
253–61.
Lam 2003
Lam NP, Donoff RB, Kaban LB, Dodson TB. Patient
satisfaction after trigeminal nerve repair. Oral Surgery, Oral
Medicine, Oral Pathology, Oral Radiology and Endodontics
2003;95(5):538–43.
16Interventions for iatrogenic inferior alveolar and lingual nerve injury (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Mason 1988
Mason DA. Lingual nerve damage following lower
third molar surgery. International Journal of Oral and
Maxillofacial Surgery 1988;17(5):290–4.
Meyer 2001
Meyer RA, Rath EM. Sensory rehabilitation after trigeminal
nerve injury or nerve repair. Oral and Maxillofacial Surgery
Clinics of North America 2001;13(2):365–76.
Rath 2002
Rath EM. Skeletal muscle autograft for repair of the human
inferior alveolar nerve: a case report. Journal of Oral and
Maxillofacial Surgery 2002;60(3):330–4.
Rood 1990
Rood JP, Shebab BA. The radiological prediction of inferior
alveolar nerve injury during third molar surgery. British
Journal of Oral and Maxillofacial Surgery 1990;28(1):20–5.
Wessberg 1982
Wessberg GA, Wolford LM, Epker BN. Experiences with
microsurgical reconstruction of the inferior alveolar nerve.
Journal of Oral and Maxillofacial Surgery 1982;40(10):
651–5.
Ziccardi 2007
Ziccardi VB, Zuniga JR. Nerve injuries after third molar
removal. Oral and Maxillofacial Surgery Clinics of North
America 2007;19(1):105–15.
References to other published versions of this review
Renton 2005
Renton TF, Coulthard P, Esposito M. Interventions for
iatrogenic inferior alveolar nerve injury. Cochrane Database
of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/
14651858.CD005293]
∗ Indicates the major publication for the study
17Interventions for iatrogenic inferior alveolar and lingual nerve injury (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Khullar 1996a
Methods Randomised placebo-controlled trial, parallel groups.
Participants A total of 15 patients requiring intervention due to post-surgical inferior alveolar nerve
sensory abnormalities lasting longer than 6 months were recruited to the study. The 13
patients who were evaluated in the study suffered from neurosensory deficit subsequent
to removal of mandibular wisdom teeth or mandibular fracture or mandibular sagittal
split osteotomy. Mean age 36.7 years (SD 11.1 years range 17 to 53 years)
Interventions Patients in the treatment group (n = 6 evaluated) received 20 sessions of a low-level laser
treatment (photon-plus GaA1As diode laser; Rønvig Dental, Denmark). 70 mW output
in a continuous wavelength of 820 nm; spot of 0.13 cm2; incident power density 550
mW/cm2, applied in the area of distribution of the inferior alveolar nerve. Patients in
the placebo group (n = 7 evaluated) received placebo laser treatment
Treatment was completed in 20 sessions over a period of between 39 and 69 days
Outcomes Nerve damage as assessed by mechanosensory and thermosensory testing
Notes The patients participating in the study suffered only partial loss of sensation and had a
normal response to heat pain. Onlymechanosensory and thermosensory testing was con-
ducted. None of the primary outcome measures we identified for this review were eval-
uated in the trial. Many patients showed a reduction in the area of reduced mechanop-
erception, but it was not possible to measure this accurately
Small sample size.
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “randomly divided...”
Comment: No information given about
the method of sequence generation
Allocation concealment (selection bias) Unclear risk No information given about themethod of
allocation concealment
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “treatment was conducted blind.”
Comment: Assume as placebo comparator
that participants were blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “double-blind.”
Comment: Assume that the outcome asses-
sor was blinded.
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Khullar 1996a (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “One patient in each group failed
to complete treatment because of personal
reasons.”
Comment: Drop-out low overall (1/7 laser,
1/8 placebo) and similar proportions across
groups. Reasons for drop-outs the same
Selective reporting (reporting bias) High risk Individual data reported for outcome of
nerve damage but subjective improvement
in sensory function for intervention group
reported in abstract but not appearing in
methods or results section. Patient’s subjec-
tive sensory assessment not fully reported
Other bias Low risk Study appears to be free of other sources of
bias.
Khullar 1996b
Methods Randomised placebo-controlled trial, parallel groups.
Participants A total of 16 patients were recruited and randomised. The 13 patients evaluated (aged
20-55 years) had undergone sagittal split ramus osteotomy and passed the final check-
up 2 years after surgery, but had suffered neurosensory deficit from injury to the inferior
alveolar nerve. Patients who had received damage to the inferior alveolar nerve during
the split procedure or who had the nerve dissected from the lateral ramus fragment were
excluded from the study. Mean age 35.7 years (range 20 to 55 years), 4 male 9 female
Interventions Patients in the treatment group (n = 8 evaluated) received 20 sessions of a low-level
laser treatment (4x6 J per treatment: photon-plus GaA1As diode laser; Rønvig Dental,
Denmark). 70 mW output in a continuous wavelength of 820 nm; spot of 0.13 cm2;
incident power density 550 mW/cm2, applied in the area of distribution of the inferior
alveolar nerve
The placebo group (n = 5 evaluated) received placebo treatment
The treatment was conducted in 20 sessions over a period of between 20 and 63 days
(mean 31 days)
Outcomes Patient’s subjective assessment on VAS, nerve damage as assessed by mechanosensory
and thermosensory testing
Notes The patients participating in the study suffered only partial loss of sensation and had a
normal response to heat pain. Small sample size
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
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Khullar 1996b (Continued)
Random sequence generation (selection
bias)
Unclear risk Quote: “randomly divided...”
Comment: No information given about
the method of sequence generation
Allocation concealment (selection bias) Unclear risk No information given about themethod of
allocation used.
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “TheLLL treatments and recording
of data were performed by a second doctor
not involved in the surgery. Analysis of the
data was performed by a third doctor.” ...
“conducted blind.”
Comment: Assume as placebo comparator
that participants were blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk As above. Data recording and analysis of
data were performed by different investiga-
tors not involved in the study
Incomplete outcome data (attrition bias)
All outcomes
High risk Quote: “the study consisted of 16 patients,
three of whom dropped out for personal
reasons and all of whomwere in the placebo
group.”
Comment: Drop-outs in placebo group
only and significant proportion (3/8)
Selective reporting (reporting bias) Low risk Primary and secondary outcomeswere fully
reported.
Other bias Low risk Study appears to be free of other sources of
bias.
SD = standard deviation; VAS = visual analogue scale.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Blackburn 1992 Found not to be randomised controlled trial.
Cornelius 1997 Found not to be randomised controlled trial.
Crawley 1992 Found not to be randomised controlled trial.
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(Continued)
Farole 2008 Found not to be randomised controlled trial.
Greenwood 2005 Found not to be randomised controlled trial.
Grötz 1998 Found not to be randomised controlled trial.
Hillerup 1994 Found not to be randomised controlled trial.
Hillerup 2007 Found not to be randomised controlled trial.
Hillerup 2008 Found not to be randomised controlled trial.
Joshi 2002 Found not to be randomised controlled trial.
Miloro 2000 Found not to be randomised controlled trial.
Mozsary 1984 Found not to be randomised controlled trial.
Pitta 2001 Found not to be randomised controlled trial.
Pogrel 1998 Found not to be randomised controlled trial.
Pogrel 2001 Found not to be randomised controlled trial.
Robinson 1996 Found not to be randomised controlled trial.
Rutner 2005 Found not to be randomised controlled trial.
Schultes 2000 Found not to be randomised controlled trial.
Seo 2008 Found not to be randomised controlled trial.
Strauss 2006 Found not to be randomised controlled trial.
Susarla 2007 Found not to be randomised controlled trial.
Tay 2008 Found not to be randomised controlled trial.
Zuniga 1997 Found not to be randomised controlled trial.
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Characteristics of ongoing studies [ordered by study ID]
Chiung Shing Huang
Trial name or title Sensory retraining exercise facilitates sensory recovery after bilateral sagittal split osteotomy - a randomised
controlled trial
Methods Randomised controlled trial.
Participants Inclusion criteria.
• Taiwanese adults (18-40 years old).
• Developmental dentofacial disharmony (Class III).
• Patients received orthognathic surgery (BSSO alone or with maxillary procedure).
Exclusion criteria.
• Medical condition associated with systemic neuropathy.
• Unwilling to sign informed consent.
• Congenital anomaly or acute trauma affecting the face.
• Previous facial surgery.
• Positive pain sensation at first week of post-surgery.
• Altered sensation before orthognathic surgery as numbness or unusual feeling.
• Cleft lip and palate.
Interventions Behavioural: sensory retraining protocol:
1. within 1 month after the surgery: facial massage and physical stimulation over lower face and lip, 4
times (20 minutes each time) a day;
2. 1 to 3 months after the surgery: brush and physical stimulation over lower face and lip, 4 times (20
minutes each time) a day;
3. 3 to 6 months after the surgery: brush, pin and physical stimulation over lower face and lip, 4 times
(20 minutes each time) a day.
Other name: sensory retraining.
Outcomes Sensory function test (Time frame: 1 year after surgery) (designated as safety issue: no)
The sensory function evaluation include objective and subjective examinations as the followings
• Questionnaire.
• Visual analogue scale (VAS).
• 2-point discrimination (2PD).
• Pain detection threshold (PD) tests.
• Touch sensory threshold.
Starting date April 2012.
Contact information Chiung Shing Huang, PhD, DDS; Chang Gung Memorial Hospital.
Notes This study is ongoing, but not recruiting participants.
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Yu-Fang Liao
Trial name or title Inferior alveolar nerve injury after bilateral sagittal split osteotomy in oral clefts
Methods Observational model: case control.
Time perspective: prospective.
Participants Inclusion criteria.
• Patients with non-syndromic cleft lip and palate (age, > 16 for females, > 18 for males), who will
undergo Dal Pont type BSSO as a part of the correction of their dentofacial deformities, from Chang Gung
Craniofacial Center, Taoyuan.
Exclusion criteria.
• Patients with history of previous BSSO or mandibular fracture.
• Patients with craniofacial anomaly.
• Patients with inferior alveolar nerve disturbances before BSSO.
• Patients with inferior alveolar nerve being cut or drilled at BSSO.
• Patients who are non-compliant with test or test schedule.
• Patients who are reluctant to sign informed consent.
Interventions 1. Determine the incidence of inferior alveolar nerve injury after BSSO.
2. Identify the risk factors associated with such injuries.
3. Understand the consequences of such injuries including the degree of neurologic recovery by
performing a prospective, longitudinal study.
Outcomes Assessment of changes in neurosensory function (Time frame: before surgery and 12 months after surgery)
(Designated as safety issue: no)
1. Subjective assessment.
2. Objective assessment: (1) 2-point (2-PD) discrimination, (2) light touch (LT) detection, (3) sharp-
and-blunt nociception test.
Starting date June 2013.
Contact information Yu-Fang Liao, PhD; Department of Craniofacial Orthodontics, Chang Gung Memorial Hospital
Notes This study is not yet open for participant recruitment.
May not be randomised controlled trial.
BSSO = bilateral sagittal split osteotomy.
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D A T A A N D A N A L Y S E S
This review has no analyses.
A D D I T I O N A L T A B L E S
Table 1. Risk of bias categories and description
Risk of bias Interpretation Within a study Across studies
Low risk of bias Plausible bias unlikely to seriously
alter the results
Low risk of bias for all key domains Most information is from studies at
low risk of bias
Unclear risk of bias Plausible bias that raises some
doubt about the results
Unclear risk of bias for one or more
key domains
Most information is from studies at
low or unclear risk of bias
High risk of bias Plausible bias that seriously weak-
ens confidence in the results
High risk of bias for one or more
key domains
The proportion of information
from studies at high risk of bias is
sufficient to affect the interpreta-
tion of results
A P P E N D I C E S
Appendix 1. Cochrane Oral Health Group’s Trials Register search strategy
The search strategy for the Cochrane Oral Health Group’s Trials Register has been amended for the Cochrane Register of Studies:
#1 ((“inferior dental nerve*” or “inferior alveolar nerve*” or “mandibular nerve*” or “trigeminal nerve*” or “lingual nerve*” or “lingual
dental nerve*”)) AND (INREGISTER)
#2 ((“sensory disturbance*” or “taste disorder*” or “neurosensory deficit*” or “somatosensory disorder*” or hyperalgesia or hypoaesthesia
or paraesthesia or hyposthesia or paraesthesia or injur* or damag* or contus* or section* or trauma* or lesion* or morbid*)) AND
(INREGISTER)
#3 ((repair* or surg* or anastamos* or graft* or medical* or analgesi* or antidepressant* or anti-depressant* or antiepileptic* or anti-
epileptic*)) AND (INREGISTER)
#4 (#1 and #2 and #3) AND (INREGISTER)
The original version of this review used the following search strategy for the ProCite software:
((“inferior dental nerve*” or “inferior alveolar nerve*” or “mandibular nerve*” or “trigeminal nerve*” or “lingual nerve*” or “lingual
dental nerve*”) AND(“sensory disturbance” or “taste disorder*” or “neurosensory deficit*” or “somatosensory disorder*” or hyperalgesia
or hypaesthesia or paresthesia or hypesthesia or paraesthesia or inju* or damage* or contus* or section* or trauma* or lesion* or morbid*)
AND (repair* or surg* or anastamos* or graft* or medical* or analgesi* or antidepressant* or anti-depressant* or antiepileptic* or anti-
epileptic*))
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Appendix 2. CENTRAL search strategy
#1 (inferior next dental next nerve* in All Text or inferior next alveolar next nerve* in All Text or mandibular next nerve* in All Text
or trigeminal next nerve* in All Text)
#2 “inferior alveolar nerve” in All Text
#3 (lingual next dental next nerve* in All Text or lingual next nerve* in All Text)
#4 MeSH descriptor Mandibular nerve this term only
#5 MeSH descriptor Lingual Nerve this term only
#6 (#1 or #2 or #3 or #4 or #5)
#7 sensory next disturbance in All Text
#8 MeSH descriptor Somatosensory disorders explode all trees
#9 MeSH descriptor Taste disorders this term only
#10 (hyperalgesia in All Text or hypesthesia in All Text or paresthesia in All Text or hypaesthesia in All Text or paraesthesia in All Text
or “taste disorder*” in All Text)
#11 (injur* in All Text or damage* in All Text or contus* in All Text or section* in All Text or trauma* in All Text or lesion* in All Text
or morbid* in All Text or neurosensory next deficit* in All Text)
#12 (#7 or #8 or #9 or #10 or #11)
#13 (#6 and #12)
#14 (repair* in All Text or surg* in All Text or anastamos* in All Text or graft* in All Text)
#15 MeSH descriptor Neurosurgical procedures this term only
#16 neurolysis in All Text
#17 (medical* in All Text or analgesi* in All Text or antidepressant* in All Text or anti-depressant* in All Text or antiepileptic* in All
Text or anti-epileptic* in All Text)
#18 (#14 or #15 or #16 or #17)
#19 (#13 and #18)
Appendix 3. MEDLINE via OVID search strategy
1. ((inferior adj dental adj nerve$) or (inferior adj alveolar adj nerve$) or (mandibular adj nerve$) or (trigeminal adj nerve$)).mp.
2. “inferior alveolar nerve$”.mp.
3. (lingual adj dental adj nerve$) or (“lingual adj nerve$”).mp.
4. MANDIBULAR NERVE/
5. INFERIOR ALVEOLAR NERVE/
6. LINGUAL NERVE/
7. or/1-6
8. (sensory adj disturbance).mp.
9. exp SOMATOSENSORY DISORDERS/
10. TASTE DISORDERS/
11. (hyperalgesia or hypesthesia or paresthesia or hypaesthesia or paraesthesia or “taste disorder”).mp.
12. (injur$ or damage$ or contus$ or section$ or trauma$ or lesion$ or morbid$ or (neurosensory adj deficit)).mp.
13. or/8-12
14. 7 and 13
15. (repair$ or surg$ or anastamos$ or graft$).mp.
16. NEUROSURGICAL PROCEDURES/
17. neurolysis.mp.
18. (medical$ or analgesi$ or antidepressant$ or anti-depressant$ or antiepileptic$ or anti-epileptic$).mp.
19. or/15-18
20. 14 and 19
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Appendix 4. EMBASE via OVID search strategy
1. ((inferior adj dental adj nerve$) or (inferior adj alveolar adj nerve$) or (mandibular adj nerve$) or (trigeminal adj nerve$)).mp.
2. “inferior alveolar nerve$”.mp.
3. (lingual adj dental adj nerve$) or (“lingual adj nerve$”).mp.
4. MANDIBULAR NERVE/
5. INFERIOR ALVEOLAR NERVE/
6. LINGUAL NERVE/
7. or/1-6
8. (sensory adj disturbance).mp.
9. exp SOMATOSENSORY DISORDERS/
10. TASTE DISORDERS/
11. (hyperalgesia or hypesthesia or paresthesia or hypaesthesia or paraesthesia or “taste disorder”).mp.
12. (injur$ or damage$ or contus$ or section$ or trauma$ or lesion$ or morbid$ or (neurosensory adj deficit)).mp.
13. or/8-12
14. 7 and 13
15. (repair$ or surg$ or anastamos$ or graft$).mp.
16. NEUROSURGICAL PROCEDURES/
17. neurolysis.mp.
18. (medical$ or analgesi$ or antidepressant$ or anti-depressant$ or antiepileptic$ or anti-epileptic$).mp.
19. or/15-18
20. 14 and 19
The above subject search was linked to the Cochrane Oral Health Group filter for identifying randomised controlled trials in EMBASE
via OVID:
1. random$.ti,ab.
2. factorial$.ti,ab.
3. (crossover$ or cross over$ or cross-over$).ti,ab.
4. placebo$.ti,ab.
5. (doubl$ adj blind$).ti,ab.
6. (singl$ adj blind$).ti,ab.
7. assign$.ti,ab.
8. allocat$.ti,ab.
9. volunteer$.ti,ab.
10. CROSSOVER PROCEDURE.sh.
11. DOUBLE-BLIND PROCEDURE.sh.
12. RANDOMIZED CONTROLLED TRIAL.sh.
13. SINGLE BLIND PROCEDURE.sh.
14. or/1-13
15. ANIMAL/ or NONHUMAN/ or ANIMAL EXPERIMENT/
16. HUMAN/
17. 16 and 15
18. 15 not 17
19. 14 not 18
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H I S T O R Y
Protocol first published: Issue 2, 2005
Review first published: Issue 4, 2014
Date Event Description
5 September 2008 Amended Converted to new review format.
C O N T R I B U T I O N S O F A U T H O R S
Conceiving, designing and co-ordination of the review (Tara Renton (TR), Paul Coulthard (PC)).
Developing the search strategy and undertaking the searches (PC, Evgeny Kushnerev (EK)).
Screening search results and retrieval of papers against inclusion criteria (PC, EK, Tanya Walsh (TW)).
Appraising quality and extracting data from papers (PC, EK, Julian M Yates (JMY), TW).
Writing to authors for additional information (EK, JMY).
Data management for the review and entering data into RevMan (PC, EK, TW).
Analysis and interpretation of data (PC, EK, JMY, Neil Patel (NP), Edmund Bailey (EB), TW).
Writing the review (PC, EK, TW).
Providing general advice on the review and proofreading (PC, TR, JMY, NP, EB, TW).
Performing previous work that was the foundation of current study (TR, PC).
D E C L A R A T I O N S O F I N T E R E S T
Paul Coulthard, Evgeny Kushnerev, Julian M Yates, Tanya Walsh, Neil Patel, Edmund Bailey, Tara F Renton: no interests to declare.
S O U R C E S O F S U P P O R T
Internal sources
• Queen Mary University London, UK.
• The University of Manchester, UK.
• The Sahlgrenska Academy at Goteborg University, Sweden.
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External sources
• Cochrane Oral Health Group Global Alliance, UK.
All reviews in the Cochrane Oral Health Group are supported by Global Alliance member organisations (British Association of Oral
Surgeons, UK; British Orthodontic Society, UK; British Society of Paediatric Dentistry, UK; British Society of Periodontology, UK;
Canadian Dental Hygienists Association, Canada; National Center for Dental Hygiene Research & Practice, USA; Mayo Clinic,
USA; New York University College of Dentistry, USA; and Royal College of Surgeons of Edinburgh, UK) providing funding for the
editorial process (http://ohg.cochrane.org/).
• National Institute for Health Research (NIHR), UK.
CRG funding acknowledgement:
The NIHR is the largest single funder of the Cochrane Oral Health Group.
Disclaimer:
The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the NIHR, NHS or the
Department of Health.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We wrote two separate protocols describing interventions for iatrogenic inferior alveolar nerve injury (0094) and interventions for
iatrogenic lingual nerve injury (0093). These were almost identical and therefore the protocols were merged into a single protocol
’Interventions for iatrogenic inferior alveolar and lingual nerve injury’ (0094) in 2009. The new search strategy has been developed for
this review since the original protocols were written.
The primary outcome of ’altered sensation’ in the protocol has been changed to ’patient-reported altered sensation’ for the review.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Iatrogenic Disease; Lingual Nerve Injuries [∗radiotherapy]; Low-Level Light Therapy [∗methods]; Randomized Controlled Trials as
Topic; Somatosensory Disorders [etiology; ∗radiotherapy]; Time Factors; Trigeminal Nerve Injuries [∗radiotherapy]
MeSH check words
Humans
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